Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Human prostate luminal epithelia adopt a club-like state in response to low androgen levels

ABSTRACT: Spatial transcriptomics of treatment naive and 5-alpha reductase inhibitior treated human BPH tissue

ORGANISM(S): Homo sapiens

PROVIDER: GSE178934 | GEO | 2021/12/16

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Human prostate luminal epithelia adopt a club-like state in response to low androgen levels (spatial and single-cell transcriptomics)

Project description:This SuperSeries is composed of the SubSeries listed below.

2021-12-16 | GSE179615 | GEO

ESR1+ luminal epithelial cells contribute to androgen-independent prostate survival in the absence of SRD5A2

Project description:Steroid 5α reductase 2 (SRD5A2) is crucial for prostatic development, converting testosterone to dihydrotestosterone (DHT). While 5α reductase inhibitors (5ARI) effectively reduce prostate size in benign prostate hyperplasia (BPH), their limited efficacy against BPH-related lower urinary tract symptoms (LUTS) and mechanisms of 5ARI resistance remain unclear. Here, we developed a Srd5a2-/- mouse model and employed single-cell RNA sequencing (scRNA-seq) to explore the impact of SRD5A2 absence on prostate cellular heterogeneity. Significant alterations in luminal epithelial (LE) populations were observed, alongside increased proportion and proliferative phenotype of estrogen receptor 1 (ESR1)+ Luminal Epithelia 2 (LE2) cells, following an SRD5A2-independent ESR1 differentiation trajectory. LE2 cells exhibited enhanced estrogen response gene signatures, suggesting alternative pathways for prostate growth without SRD5A2. Human prostate biopsy analysis revealed an inverse correlation between SRD5A2 expression and LE2 markers (ESR1 and PKCα). These findings provide insights into prostate biology, 5ARI resistance mechanisms, and potential targeted therapies for BPH-related LUTS.

2023-06-26 | GSE235514 | GEO

Human prostate luminal epithelia adopt a club-like state in response to low androgen levels

Project description:Human prostate luminal epithelia adopt a club-like state in response to low androgen levels

| PRJNA741514 | ENA

Human prostate luminal epithelia adopt a club-like state in response to low androgen levels (spatial and single-cell transcriptomics)

Project description:Human prostate luminal epithelia adopt a club-like state in response to low androgen levels (spatial and single-cell transcriptomics)

| PRJNA744277 | ENA

The effect of high fat diet on mouse prostate development

Project description:Steroid 5α reductase 2 (SRD5A2) is the predominant enzyme responsible for prostatic development and growth. Despite the introduction of steroid 5α-reductase inhibitors (5ARI) for benign prostatic hyperplasia (BPH), the progression of LUTS is only slowed by 34% with 5ARI-response. Previous literature establishes link between obesity and BPH progression. We hypothesize that high fat diet is associated with prostate development.

2024-03-03 | GSE260450 | GEO

Gene expression profiling of AR deletion in prostate luminal cells

Project description:Benign prostatic hyperplasia (BPH) is a common urological disease that adversely affects quality of life among elderly males, but its etiology remains poorly understood. We show that the expression of the androgen receptor (AR) is decreased in the luminal epithelial cells of human BPH specimens and is inversely correlated with the degree of regional prostatic inflammation.

2016-09-27 | GSE77646 | GEO

Transepithelial projections from basal cells are luminal sensors in pseudostratified epithelia.

Project description: Not available

| S-EPMC2646085 | biostudies-literature

Urethral luminal epithelia are castration-insensitive cells of the proximal prostate.

Project description: Not available

| S-EPMC7339731 | biostudies-literature

Therapeutic potential of pomegranate juice-derived nanovesicles in nude mouse benign prostatic hyperplasia (BPH) xenograft model

Project description:Benign prostatic hyperplasia (BPH) and associated lower urinary tract symptoms affect a large percentage of the male population and places a substantial burden on the world health system. Current therapies include 5-alpha reductase inhibitors and alpha-blockers that are only partially effective and pose a huge economic burden, emphasizing the urgent need for effective, economical therapies. We isolated nanovesicles from pomegranate juice (Punica Granatum) (referred to as ‘POM-NVs’) and report to our knowledge for the first time, that these vesicles possess therapeutic potential against BPH. Following extensive characterization of POM-NVs, we tested their therapeutic potential in vitro using BPH1 cell line and identified a potential anti-proliferative and pro-apoptotic effect. We further tested these vesicles using a clinically relevant xenograft mouse BPH model derived from human BPH tissues. Remarkably, POM-NVs could reverse the BPH phenotype conferred by TGF-β mediated signaling and induced epithelial-to-mesenchymal (EMT) reversal, leading to the restoration of prostate epithelial states in vivo and in vitro. Furthermore, these vesicles attenuated bone morphogenic protein 5 (BMP5) signaling, a cardinal alteration that is instrumental in driving BPH. Considering the large incidences of BPH and its associated economic burdens, our study has important implications and can potentially improve the clinical management of BPH.

2023-07-18 | PXD043608 | Pride

Differential gene expressions for androgen-induced benign prostatic hyperplysia rat underwent oral treatment of metabolic peptide ghrelin

Project description:To preliminary distinguish differential gene expressions in BPH-rat prostate after oral treatment of ghrelin.

2019-04-11 | GSE129561 | GEO